Company Filing History:
2 out of 38 
1 out of 1,391 
1 out of 1 Years Active: 2011-2024
Title: Innovations and Contributions of Inventor Qian Wang
Introduction
Qian Wang is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of immunology and drug development, holding a total of six patents. His work focuses on innovative solutions for combating viral infections and developing therapeutic agents.
Latest Patents
One of Qian Wang's latest patents is the "AD35-vectored immunogenic composition for SARS-COV-2 infection." This invention discloses a replication-defective Ad35-vectored immunogenic composition designed to induce an immune response against SARS-CoV-2. The composition includes an Ad35 vector that encodes an optimized nucleic acid sequence. The findings suggest that this immunogenic composition can produce more S proteins in human cells, enhancing safety and convenience. It may also be used in combination with other immunogenic compositions or as a therapeutic agent for COVID-19.
Another significant patent is related to "Myrtle polysaccharide P1, the separation method thereof and the use in preparing hypolipidemic drugs." This invention details a myrtle polysaccharide P1, which contains various sugars and demonstrates the ability to bind cholate in vitro. The experimental results indicate that the myrtle polysaccharide P1 has a binding rate to sodium taurocholate, sodium glycocholate, and sodium cholate, showcasing its potential in hypolipidemic drug development.
Career Highlights
Qian Wang has worked with prominent institutions, including South China Normal University and Cooper Technologies Company. His experience in these organizations has contributed to his innovative research and development efforts.
Collaborations
Qian Wang has collaborated with notable colleagues, including Ruqiang Huang and Jinghui Wang, who have supported his research endeavors.
Conclusion
Qian Wang's contributions to the fields of immunology and drug development are noteworthy. His innovative patents reflect his commitment to advancing medical science and improving therapeutic options for viral infections and related health issues.